New GLP-1 Weight Loss Pills May Strain Employer Insurance Coverage Due to Rising Costs
Novo Nordisk and Eli Lilly have launched oral versions of their popular GLP-1 weight loss medications, but employers are facing rising costs that may lead them to reduce coverage. Despite similar pricing compared to injectables, increased demand for the pills is causing concern among large employers.
Topics: drug costs employer coverage GLP-1 medications weight loss pills